Business Description
SunWay Biotech Co Ltd
ISIN : TW0001271005
Share Class Description:
ROCO:1271: Ordinary SharesTotal Employee Number:
59Compare
Compare
Traded in other countries / regions
1271.Taiwan IPO Date
2021-01-18Description
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.34 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | 4.49 | |||||
Interest Coverage | 9.25 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.34 | |||||
Beneish M-Score | -2.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.8 | |||||
3-Year EBITDA Growth Rate | 10.9 | |||||
3-Year EPS without NRI Growth Rate | 4.5 | |||||
3-Year FCF Growth Rate | -0.1 | |||||
3-Year Book Growth Rate | 85.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.06 | |||||
9-Day RSI | 50.31 | |||||
14-Day RSI | 50.49 | |||||
3-1 Month Momentum % | 8.7 | |||||
6-1 Month Momentum % | 16.91 | |||||
12-1 Month Momentum % | 9.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.62 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 0.62 | |||||
Days Inventory | 186.33 | |||||
Days Sales Outstanding | 95.08 | |||||
Days Payable | 32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.18 | |||||
Dividend Payout Ratio | 0.79 | |||||
3-Year Dividend Growth Rate | -32 | |||||
Forward Dividend Yield % | 2.18 | |||||
5-Year Yield-on-Cost % | 2.09 | |||||
3-Year Average Share Buyback Ratio | -20.8 | |||||
Shareholder Yield % | -9.64 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.43 | |||||
Operating Margin % | 10.48 | |||||
Net Margin % | 10.22 | |||||
EBITDA Margin % | 19.88 | |||||
FCF Margin % | 11.97 | |||||
OCF Margin % | 22.44 | |||||
ROE % | 3.12 | |||||
ROA % | 2.45 | |||||
ROIC % | 2.59 | |||||
3-Year ROIIC % | 1.63 | |||||
ROC (Joel Greenblatt) % | 15.78 | |||||
ROCE % | 3.43 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 37.44 | |||||
PE Ratio without NRI | 37.44 | |||||
Price-to-Owner-Earnings | 18.81 | |||||
PS Ratio | 3.82 | |||||
PB Ratio | 1.17 | |||||
Price-to-Tangible-Book | 4.27 | |||||
Price-to-Free-Cash-Flow | 31.92 | |||||
Price-to-Operating-Cash-Flow | 17.02 | |||||
EV-to-EBIT | 34.48 | |||||
EV-to-EBITDA | 22.12 | |||||
EV-to-Revenue | 4.39 | |||||
EV-to-FCF | 36.95 | |||||
Price-to-GF-Value | 0.88 | |||||
Price-to-Graham-Number | 2.67 | |||||
Earnings Yield (Greenblatt) % | 2.89 | |||||
FCF Yield % | 3.15 | |||||
Forward Rate of Return (Yacktman) % | -3.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SunWay Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 993.303 | ||
| EPS (TTM) (NT$) | 1.68 | ||
| Beta | -0.3057 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.67 | ||
| Volatility % | 31.27 | ||
| 14-Day RSI | 50.49 | ||
| 14-Day ATR (NT$) | 2.249863 | ||
| 20-Day SMA (NT$) | 62.59 | ||
| 12-1 Month Momentum % | 9.8 | ||
| 52-Week Range (NT$) | 51 - 90.8 | ||
| Shares Outstanding (Mil) | 60.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SunWay Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SunWay Biotech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.330529 Cash Dividend | 2025-07-16 | 59.20 (-1.33%) | ||
| 1.01684:1 Stock Split | 2024-12-09 | 86.84 (+0.00%) |
Show
Entries
SunWay Biotech Co Ltd Frequently Asked Questions
What is SunWay Biotech Co Ltd(ROCO:1271)'s stock price today?
The current price of ROCO:1271 is NT$62.90. The 52 week high of ROCO:1271 is NT$90.80 and 52 week low is NT$51.00.
When is next earnings date of SunWay Biotech Co Ltd(ROCO:1271)?
The next earnings date of SunWay Biotech Co Ltd(ROCO:1271) is .
Does SunWay Biotech Co Ltd(ROCO:1271) pay dividends? If so, how much?
The Dividend Yield %  of SunWay Biotech Co Ltd(ROCO:1271) is 2.18% (As of Today), Highest Dividend Payout Ratio of SunWay Biotech Co Ltd(ROCO:1271) was 2.88. The lowest was 0.5. And the median was 0.79. The  Forward Dividend Yield % of SunWay Biotech Co Ltd(ROCO:1271) is 2.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on SunWay Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers